Repatha 72511-0393
Generic: Evolocumab
Product NDC
72511-0393- Manufacturer
- Amgen Usa Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 24, 2024
- Listing Expires
- December 31, 2027
- Application
- BLA125522
Need to source Repatha? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Evolocumab | 140 mg/mL |
Drug Class
PCSK9 Inhibitor [EPC]AntibodiesMonoclonal [CS]
Packaging Options(3)
1 SYRINGE in 1 CARTON (72511-393-01) / 1 mL in 1 SYRINGE
2 SYRINGE in 1 CARTON (72511-393-02) / 1 mL in 1 SYRINGE
1 SYRINGE in 1 CARTON (72511-393-96) / 1 mL in 1 SYRINGE